vs
Penumbra Inc（PEN）与Stitch Fix, Inc.（SFIX）财务数据对比。点击上方公司名可切换其他公司
Penumbra Inc的季度营收约是Stitch Fix, Inc.的1.1倍（$385.4M vs $342.1M），Penumbra Inc净利率更高（12.3% vs -1.9%，领先14.1%），Penumbra Inc同比增速更快（22.1% vs 7.3%），Penumbra Inc自由现金流更多（$68.0M vs $5.6M），过去两年Penumbra Inc的营收复合增速更高（17.6% vs 1.8%）
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
Stitch Fix是美国的在线个人造型服务平台，依托推荐算法与数据科学技术，根据顾客的身形尺寸、预算和风格偏好推送个性化服饰单品。该公司创立于2011年，2017年完成首次公开募股，目前总部位于旧金山。
PEN vs SFIX — 直观对比
营收规模更大
PEN
是对方的1.1倍
$342.1M
营收增速更快
PEN
高出14.8%
7.3%
净利率更高
PEN
高出14.1%
-1.9%
自由现金流更多
PEN
多$62.5M
$5.6M
两年增速更快
PEN
近两年复合增速
1.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $385.4M | $342.1M |
| 净利润 | $47.3M | $-6.4M |
| 毛利率 | 68.0% | 43.6% |
| 营业利润率 | 15.4% | -2.5% |
| 净利率 | 12.3% | -1.9% |
| 营收同比 | 22.1% | 7.3% |
| 净利润同比 | 40.6% | -1.7% |
| 每股收益（稀释后） | $1.20 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PENSFIX
| Q4 25 | $385.4M | $342.1M | ||
| Q3 25 | $354.7M | $311.2M | ||
| Q2 25 | $339.5M | $325.0M | ||
| Q1 25 | $324.1M | $312.1M | ||
| Q4 24 | $315.5M | $318.8M | ||
| Q3 24 | $301.0M | $319.6M | ||
| Q2 24 | $299.4M | $322.7M | ||
| Q1 24 | $278.7M | $330.4M |
净利润PENSFIX
| Q4 25 | $47.3M | $-6.4M | ||
| Q3 25 | $45.9M | $-8.6M | ||
| Q2 25 | $45.3M | $-7.4M | ||
| Q1 25 | $39.2M | $-6.5M | ||
| Q4 24 | $33.7M | $-6.3M | ||
| Q3 24 | $29.5M | $-36.5M | ||
| Q2 24 | $-60.2M | $-21.3M | ||
| Q1 24 | $11.0M | $-35.5M |
毛利率PENSFIX
| Q4 25 | 68.0% | 43.6% | ||
| Q3 25 | 67.8% | 43.6% | ||
| Q2 25 | 66.0% | 44.2% | ||
| Q1 25 | 66.6% | 44.5% | ||
| Q4 24 | 66.8% | 45.4% | ||
| Q3 24 | 66.5% | 44.6% | ||
| Q2 24 | 54.4% | 45.5% | ||
| Q1 24 | 65.0% | 43.4% |
营业利润率PENSFIX
| Q4 25 | 15.4% | -2.5% | ||
| Q3 25 | 13.8% | -3.6% | ||
| Q2 25 | 12.0% | -3.0% | ||
| Q1 25 | 12.4% | -2.9% | ||
| Q4 24 | 13.6% | -2.8% | ||
| Q3 24 | 11.7% | -13.1% | ||
| Q2 24 | -27.0% | -7.7% | ||
| Q1 24 | 4.3% | -11.5% |
净利率PENSFIX
| Q4 25 | 12.3% | -1.9% | ||
| Q3 25 | 12.9% | -2.8% | ||
| Q2 25 | 13.3% | -2.3% | ||
| Q1 25 | 12.1% | -2.1% | ||
| Q4 24 | 10.7% | -2.0% | ||
| Q3 24 | 9.8% | -11.4% | ||
| Q2 24 | -20.1% | -6.6% | ||
| Q1 24 | 3.9% | -10.8% |
每股收益（稀释后）PENSFIX
| Q4 25 | $1.20 | $-0.05 | ||
| Q3 25 | $1.17 | $-0.06 | ||
| Q2 25 | $1.15 | $-0.06 | ||
| Q1 25 | $1.00 | $-0.05 | ||
| Q4 24 | $0.88 | $-0.05 | ||
| Q3 24 | $0.75 | $-0.29 | ||
| Q2 24 | $-1.55 | $-0.18 | ||
| Q1 24 | $0.28 | $-0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $186.9M | $244.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $204.1M |
| 总资产 | $1.8B | $530.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PENSFIX
| Q4 25 | $186.9M | $244.2M | ||
| Q3 25 | $321.0M | $234.9M | ||
| Q2 25 | $421.8M | $234.2M | ||
| Q1 25 | $376.1M | $219.1M | ||
| Q4 24 | $324.4M | $253.3M | ||
| Q3 24 | $280.5M | $247.0M | ||
| Q2 24 | $288.3M | $244.5M | ||
| Q1 24 | $223.1M | $229.8M |
股东权益PENSFIX
| Q4 25 | $1.4B | $204.1M | ||
| Q3 25 | $1.4B | $203.0M | ||
| Q2 25 | $1.3B | $200.4M | ||
| Q1 25 | $1.2B | $197.8M | ||
| Q4 24 | $1.2B | $190.5M | ||
| Q3 24 | $1.1B | $187.0M | ||
| Q2 24 | $1.2B | $208.9M | ||
| Q1 24 | $1.2B | $213.3M |
总资产PENSFIX
| Q4 25 | $1.8B | $530.7M | ||
| Q3 25 | $1.7B | $480.6M | ||
| Q2 25 | $1.7B | $484.7M | ||
| Q1 25 | $1.6B | $472.6M | ||
| Q4 24 | $1.5B | $507.1M | ||
| Q3 24 | $1.5B | $486.9M | ||
| Q2 24 | $1.5B | $537.0M | ||
| Q1 24 | $1.6B | $538.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $86.5M | $10.9M |
| 自由现金流经营现金流 - 资本支出 | $68.0M | $5.6M |
| 自由现金流率自由现金流/营收 | 17.7% | 1.6% |
| 资本支出强度资本支出/营收 | 4.8% | 1.6% |
| 现金转化率经营现金流/净利润 | 1.83× | — |
| 过去12个月自由现金流最近4个季度 | $174.9M | $4.9M |
8季度趋势，按日历期对齐
经营现金流PENSFIX
| Q4 25 | $86.5M | $10.9M | ||
| Q3 25 | $58.3M | $7.0M | ||
| Q2 25 | $44.9M | $20.5M | ||
| Q1 25 | $49.0M | $-16.2M | ||
| Q4 24 | $51.1M | $14.3M | ||
| Q3 24 | $56.5M | $8.2M | ||
| Q2 24 | $22.6M | $21.7M | ||
| Q1 24 | $38.3M | $-22.3M |
自由现金流PENSFIX
| Q4 25 | $68.0M | $5.6M | ||
| Q3 25 | $42.0M | $2.8M | ||
| Q2 25 | $29.4M | $16.0M | ||
| Q1 25 | $35.5M | $-19.4M | ||
| Q4 24 | $45.7M | $9.9M | ||
| Q3 24 | $51.0M | $4.5M | ||
| Q2 24 | $18.1M | $18.9M | ||
| Q1 24 | $32.5M | $-26.1M |
自由现金流率PENSFIX
| Q4 25 | 17.7% | 1.6% | ||
| Q3 25 | 11.8% | 0.9% | ||
| Q2 25 | 8.7% | 4.9% | ||
| Q1 25 | 11.0% | -6.2% | ||
| Q4 24 | 14.5% | 3.1% | ||
| Q3 24 | 16.9% | 1.4% | ||
| Q2 24 | 6.0% | 5.9% | ||
| Q1 24 | 11.7% | -7.9% |
资本支出强度PENSFIX
| Q4 25 | 4.8% | 1.6% | ||
| Q3 25 | 4.6% | 1.4% | ||
| Q2 25 | 4.6% | 1.4% | ||
| Q1 25 | 4.2% | 1.0% | ||
| Q4 24 | 1.7% | 1.4% | ||
| Q3 24 | 1.8% | 1.2% | ||
| Q2 24 | 1.5% | 0.9% | ||
| Q1 24 | 2.1% | 1.1% |
现金转化率PENSFIX
| Q4 25 | 1.83× | — | ||
| Q3 25 | 1.27× | — | ||
| Q2 25 | 0.99× | — | ||
| Q1 25 | 1.25× | — | ||
| Q4 24 | 1.52× | — | ||
| Q3 24 | 1.91× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
SFIX
暂无分部数据
